Congress has been talking about this for a long time, but we're taking action. We encourage them to act, but in the meantime, we're not wasting time. When Humira, the powerful biologic which works wonders, came off patent, it took seven years for a biosimilar to come to market. Why? Because of these burdensome, onerous bureaucratic red tape requirements in part at the fda. The fundamental problem in healthcare is that we have non competitive markets. (14:00–14:10)
CLAIM
Asserts that it took seven years for a Humira biosimilar to come to market after the patent expired.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.